Viatris (VTRS) Shares Outstanding (Diluted Average) (2018 - 2021)
Viatris (VTRS) recorded quarterly Shares Outstanding (Diluted Average) of $1.2 billion in Q2 2021, little changed quarter-over-quarter from $1.2 billion in Q1 2021.
Viatris (VTRS) Shares Outstanding (Diluted Average) (2018 - 2021) Analysis & Trends
Viatris' Shares Outstanding (Diluted Average) history runs 4 years deep, the most recent figure standing at $1.2 billion for Q2 2021.
- In Q2 2021, Shares Outstanding (Diluted Average) changed N/A year-over-year to $1.2 billion; the TTM figure through Jun 2021 stood at $1.2 billion (changed N/A YoY), while the FY2019 annual figure was $516.5 million, changed 0.0% from the prior year.
- Shares Outstanding (Diluted Average) was $1.2 billion for Q2 2021 at Viatris, roughly flat from $1.2 billion in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $1.2 billion in Q2 2021 to a low of $516.5 million in Q4 2018.
- Historically, Shares Outstanding (Diluted Average) has averaged $793.1 million across 4 years, with a median of $517.0 million in 2020.
- The sharpest annual moves came in 2019 and 2021: Shares Outstanding (Diluted Average) changed 0.0% in 2019, then soared 133.56% in 2021.
- A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $516.5 million in 2018, then changed by 0.0% to $516.5 million in 2019, then advanced by 0.1% to $517.0 million in 2020, then surged by 133.69% to $1.2 billion in 2021.
- The last three Shares Outstanding (Diluted Average) figures came in at $1.2 billion (Q2 2021), $1.2 billion (Q1 2021), and $517.0 million (Q1 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Viatris | - | - | 1.16 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 1.21 Bn |
| Mar 31, 2021 | 1.21 Bn |
| Mar 31, 2020 | 517.00 Mn |
| Dec 31, 2019 | 516.50 Mn |
| Dec 31, 2018 | 516.50 Mn |